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Little  is known  about  the relationship  between  HPV  vaccine  uptake  and  other  risk  factors  for cervical  can-
cer. This  study  aimed  to measure  the association  between  vaccine  status  and  cervical  cancer  risk  factors
in  adolescent  girls.  Girls  (15–16  years)  from  the  ﬁrst  two  cohorts  to  be offered  routine  HPV  vaccination
in  the  NHS  immunisation  programme  completed  a survey  3  years  post-vaccination.  Recruitment  took
place  at 13  schools  in  London.  Of 2768  girls  registered  in  Year  11,  1912  (69%)  took  part  and  provided
analysable  data.  Questions  assessed  vaccine  status,  demographic  characteristics,  smoking  status,  sexual
behaviour  and intention  to attend  cervical  screening.  Overall,  78%  had  completed  the  three-dose  vaccine
course.  There  was no  association  between  vaccine  status  and  smoking  behaviour  or  sexual  experience.  Inervical cancer
ancer risk
dolescent
mmunisation
adjusted  analyses,  girls  from  black  or ‘other’  ethnic  backgrounds  were  less  likely  to be  fully-vaccinated
than  those  from  white  backgrounds.  Those  with  low  intentions  to  attend  cervical  screening  were  less
likely  to be fully  vaccinated  than  those  with  high  intentions.  Efforts  will  be needed  to  ensure  that  unvac-
cinated  women  understand  the importance  of  cervical  screening  when  they  reach  the  age  that  screening
begins.  Ethnic  inequalities  in  vaccine  coverage  need  to  be explored  further.
©  2014  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license. Introduction
In England, girls age 12–13 years are offered free human papillo-
avirus (HPV) vaccination in a school-based programme launched
n 2008. The programme has achieved high coverage, with latest ﬁg-
res showing that 84% and 81% of eligible girls in the ﬁrst (2008/9)
nd second (2009/10) cohorts to be offered the HPV vaccine have
eceived all three doses as recommended [1]. This relatively new
ervical cancer control policy is complemented by a long-standing
all–recall screening programme for women aged 25–64 years,
n which women receive regular screening invitations by post.
omen  aged 25–49 years are invited every 3 years and women
ged 50–64 years are invited every 5 years. Written invitations ask
omen to make an appointment for a Pap test with their general
ractitioner or primary care nurse. The programme is funded by
he NHS and is free at the point of delivery. Screening uptake in
omen aged 25–64 years is high, with 78% having been screened
t least once in the previous 5 years [2].Despite the successful screening programme, almost 3000
omen are diagnosed with cervical cancer each year in the UK,
nd about 900 women die of the disease [3]. Modelling studies have
∗ Corresponding author. Tel.: +44 020 7679 5958.
E-mail address: j.waller@ucl.ac.uk (J. Waller).
ttp://dx.doi.org/10.1016/j.vaccine.2014.06.011
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/3.0/).
estimated that 80% vaccine coverage will result in a 63% decrease
in cervical cancer incidence in 20–29 year old women by 2025 [4].
However this assumes an equal level of baseline risk of cervical
cancer in vaccinated and unvaccinated girls. If unvaccinated girls
are, in fact, at higher risk of cervical cancer for reasons other than
their vaccination status (e.g. early sexual debut, smoking or non-
attendance at screening), then the true impact of the vaccination
programme may  be less than has been anticipated. In their mod-
elling study, Cuzick and colleagues acknowledge that it is unknown
whether non-participation in vaccination and screening will be
independent of one another. They raise the possibility that vac-
cinated women  may  perceive less need for screening, but also that
factors like deprivation may be associated with non-participation
in both programmes [4]. The relationship between vaccine status
and screening participation in England will not be apparent until
about 2021, when the cohort vaccinated in 2008 will be eligible for
screening. The full impact of the vaccine on cervical abnormalities
and cancer will not be seen until even later.
Currently, the major determinant of cervical cancer risk in
England is screening attendance [5]. Screening attendance is demo-
graphically patterned, with non-white women and those with less
education and from lower socioeconomic status (SES) backgrounds
being less likely ever to attend screening [6–9]. Other major risk
factors for cervical cancer are having many sexual partners, due
to an increased risk of HPV acquisition [10], and cigarette smoking
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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After reading a brief description of the HPV vaccine (see Box 1)
participants were asked to indicate their vaccine status (responseH.L. Bowyer et al. / Va
11–13]. Smoking status is strongly related to SES [14] and ethnicity
15]; and sexual behaviour also varies by ethnic group [16]. Associ-
tions between sexual behaviour and SES are less clear-cut [17] but
omen with academic qualiﬁcations and managerial/professional
ccupations are at lower odds of having intercourse before the age
f 16 [18].
There is emerging evidence that these risk factors for cervical
ancer may  also be related to HPV vaccination status. Non-white
omen are less likely to have been vaccinated than white women
n the UK and elsewhere [19,20], and black ethnic groups are par-
icularly unlikely to be vaccinated in the US [21]. The role of religion
n vaccine initiation is less clear [21]. A social gradient in HPV vac-
ination uptake has been observed in the UK catch-up cohorts [22],
ut is less clear in the routine cohorts [23–25].
In most cases HPV vaccination is offered some years before
ervical screening and therefore few studies have examined
he association between uptake of HPV vaccination and cervi-
al screening attendance. Studies in Australia [26] and Germany
27] that have explored this have found no signiﬁcant associa-
ion, but samples have been small and have tended to include
lder women who received the vaccine on an opportunistic basis.
 larger study conducted as part of an evaluation of the immun-
sation programme in Scotland found higher intentions to attend
uture cervical screening in vaccinated girls [28], and a study in
ales found that unvaccinated women from the catch-up cohort
ere less likely to attend screening when invited at age 20 [29];
owever no such research has yet been conducted in England.
This study aimed to establish whether unvaccinated girls are
ikely to be at disproportionately higher risk of cervical cancer. We
sed data collected from vaccinated and unvaccinated girls in the
rst two cohorts of the HPV immunisation programme to consider
he association between vaccine status and (i) demographic risk
actors and (ii) behavioural risk factors for cervical cancer.
. Materials and methods
.1. Design and participants
Assuming that vaccine coverage (three doses) would be 77.5%
30], we determined that a sample size of 2000 would include
pproximately 450 unvaccinated girls, giving us 80% power to
etect a 6% difference in the proportion of these girls who  would be
exually active by the time of the survey, compared with the vacci-
ated girls (alpha = .05). We  therefore set a target of recruiting 2000
articipants over two cohorts.
Female adolescents in UK school Year 11 (age 15–16 years) were
ecruited from 13 state-funded schools across London, England in
eptember 2011. In 2008/9 these girls were in the ﬁrst cohort to
e offered the bivalent HPV vaccine at school in Year 8. A samp-
ing frame was used to randomly select state-funded schools that
aried in terms of SES and HPV vaccine uptake. Only schools that
chieved vaccine uptake levels within ±10% of the national average
n 2008/9 (80%) [30] were included (n = 89), to eliminate schools
here uptake might be unusually high or low for idiosyncratic
easons related to delivery rather than the individual character-
stics that were the focus of this study. Schools were classiﬁed as
aving achieved uptake rates above or below the national aver-
ge. School-level SES was measured using General Certiﬁcate in
econdary Education (GCSE) attainment and Free School Meal Eligi-
ility (children are eligible for free school meals if their parents are
ntitled to means-tested welfare beneﬁts from the UK government
31]). Schools were classiﬁed as being above or below the national
verage on each of these measures [32,33]. Schools were randomly
elected from each cell of the sampling frame and contacted via
mail and telephone until we reached an estimated target sample2 (2014) 4310–4316 4311
of 1000 participants, based on school roll numbers. Further details
about the sampling frame have been reported elsewhere [34].
All 89 schools were sent details of the study; 13 schools agreed to
participate, 19 refused due to scheduling difﬁculties and 57 did not
respond to our initial contact and were not re-contacted because
the target sample had been achieved. One year later, in September
2012, female adolescents in school Year 11 were recruited from
12 of the original 13 schools; one school withdrew from the study
because of scheduling difﬁculties. These girls were in the second
cohort offered the routine HPV vaccine at school (in 2009/10). Iden-
tical materials and methods were used during the two waves of data
collection.
Parents received an information sheet about the study and an
opt-out form 1 week before the research took place. Parental con-
sent was implied if the opt-out form was not returned to the school.
All girls in attendance were given an information sheet and a ques-
tionnaire booklet. Consent was implied upon completion of the
questionnaire and all girls were debriefed with an information
sheet containing information about HPV. The study was approved
by UCL research ethics committee (ref: 0630/002).
2.2. Measures
2.2.1. Demographic characteristics
Participants were asked to report their age, ethnicity, religion
and, if they reported a religious afﬁliation, to say whether they
practised their religion. Household wealth was  measured using
the Family Afﬂuence Scale [35]; a validated self-report measure
for adolescents. This measure asks adolescents how many vehicles
and computers their family owns, whether they have a bedroom to
themselves and how many holidays they have had with their family
in the past year. Items were summed to give an overall family afﬂu-
ence score (range 0–10), which was split into tertiles: ‘low’ (scores
of 0–4), ‘medium’ (scores of 5–6) and ‘high’ (scores of 7–10).
2.2.2. Risk factors for cervical cancer
Participants were asked whether they smoked (yes/no). Sexual
experience was assessed by asking participants ‘Have you ever had
vaginal sex?’ (yes/no); this question was  adapted from the ‘National
Survey of Sexual Attitudes and Lifestyles’ [17]. Expectation of hav-
ing sex in the next year was also assessed using two  items adapted
from Sheeran and Orbell [36]: ‘I expect I will have sex this year’ and
‘I think I will have sex this year’ (5-point scale: ‘strongly disagree’ to
‘strongly agree’, scored from 1 to 5). These items correlated highly
(r = 0.97) and were summed to give an overall score which was split
into tertiles: ‘no expectation’ (scores of 2), ‘low expectation’ (3–5)
and ‘high expectation’ (6–10) of having sex in the next year. Inten-
tion to attend cervical screening in the future was assessed using
similar items: ‘When I am older and am invited to go for a smear
(Pap) test, I intend to go’ and ‘When I am older and am invited to go
for a smear (Pap) test, I will try to go’ (with a 5-point response scale
as before). The items correlated highly (r = 0.89) and were summed
to give an overall screening intention score which was  split into
tertiles: ‘low intention’ (scores of 2–6), ‘medium intention’ (7–8)
and ‘high intention’ (9–10). Other measures in the questionnaire
that are not reported here have been described elsewhere [34].
2.2.3. Vaccine statusoptions: ‘I have had all 3 doses of the HPV vaccine’; ‘I have had 1 or
2 doses of the HPV vaccine’; ‘I have been offered the HPV vaccine
but I haven’t had it’; ‘I have not been offered the HPV vaccine’; ‘I
don’t know’).
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Box 1
Human papillomavirus (HPV) is a very common infection
involved in most cervical cancer.
It is transmitted via skin-to-skin contact, most commonly dur-
ing sexual activity.
A vaccine was developed that protects against this infection.
You should have been offered the HPV (cervical cancer) vaccine
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tin Year 8.
It involved having three injections over about 6 months.
.3. Analysis
Logistic regression analyses, clustering by school and cohort,
ere used to examine the association between HPV vaccine sta-
us (fully vaccinated versus un-/under-vaccinated) and other risk
actors for cervical cancer. It is necessary to adjust for clustering of
ata within schools and cohorts in order to obtain unbiased tests of
igniﬁcance. Analyses were performed using the Complex Samples
unction in SPSS v.20 [37].
. Results
.1. Sample characteristics
A total of 2162 girls agreed to participate in the study (n = 1033
rom the 2008/9 cohort and n = 1129 from the 2009/10 cohort) (see
ig. 1). The overall participation rate among girls in attendance at
he point of data collection was over 98% across both years. Eigh-
een girls and nine parents refused consent and based on the school
Girls  opted 
out/refused  (n= 18)
Girls a bsent  on day 
(n=576)
Pare nts opted  out 
(n=9)
Removed due to 
anom alous  resp onses 
(n=3)
Removed d ue to 
missi ng vacci ne statu s 
data  (n=250)
On school  reg ist er (pare nts 
received i nformaon 
sheet) (n=2768 ) 
Pre sent  on day 
(n=2183)
Complet ed ques onnai re 
(n=216 5)
Fin al sa mple  for analysis 
(n=191 2)
Fig. 1. Recruitment and sample size for data analysis.2 (2014) 4310–4316
role numbers provided 576 were absent at the time of data col-
lection. In some cases, girls may  have been present at school but
missed the data collection session due to other commitments. Other
reasons for absence are unknown. Respondents who did not know
their HPV vaccination status (n = 221/2162; 10.2%) or who failed to
report their vaccine status (n = 29/2162; 1.3%) were excluded from
analyses, leaving a sample of 1912 (69.1% (1912/2768) of the total
eligible population. Individuals who  reported having received all
three doses of the HPV vaccine were coded as ‘fully vaccinated’
(n = 1499/1912; 78.4%). Participants who  reported receiving one
or two doses of the HPV vaccine (n = 122/1912; 6.4%), had been
offered the vaccine but had not had it (n = 233/1912; 12.2%) or
had not been offered the vaccine (n = 58/1912; 3.0%) were coded
as ‘un/under-vaccinated’ (n = 413/1912; 21.6%). Vaccine status was
coded in this way because it seemed unlikely that three years on,
under-vaccinated girls would receive any additional doses of the
vaccine and these girls may  therefore be at higher risk of cervical
cancer.
Demographic characteristics of the sample are shown in Table 1.
The sample was ethnically diverse with only 44.2% reporting
being from a white background (n = 845/1912). The largest reli-
gious group was  Christian (n = 814/1912; 42.6%) and overall 40.1%
of respondents reported practising a religion (n = 767/1912). The
mean Family Afﬂuence Score was  5.57 (SD = 1.92; range: 0–10).
There were some signiﬁcant differences between cohorts (see
Table 1 for p-values). More girls in the ﬁrst cohort were Christian
(45% vs. 40%) while more in the second cohort had no religion (33%
vs. 27%). Girls in the ﬁrst cohort were more likely to report having
had vaginal sex (20% vs. 16%) and had higher screening intentions
than girls in the second cohort (35% vs. 28%).
3.2. Vaccine status and demographic risk factors
In unadjusted analyses there was  a signiﬁcant association
between vaccine status and ethnicity; girls from all non-white eth-
nic backgrounds were signiﬁcantly less likely to be fully vaccinated
than those from white ethnic backgrounds (white: 85%, non-white:
69–78%; see Table 2). There was also a signiﬁcant association
between vaccine status and religion; girls with no religious afﬁl-
iation were more likely to be fully vaccinated than Christian girls
(85% vs. 77%). There appeared to be a linear association between
vaccine status and family afﬂuence, but this did not reach statisti-
cal signiﬁcance. There was no association between vaccine status
and religiosity. After adjusting for ethnicity, religion was no longer
signiﬁcantly associated with vaccine status. However, the ethnicity
association remained signiﬁcant after adjusting for religion; girls
from black and ‘other’ ethnic backgrounds were less likely to be
fully vaccinated than girls from white backgrounds.
3.3. Vaccine status and behavioural risk factors
There was no association between vaccine status and current
risk behaviours: smoking status or sexual experience. There was
no association between vaccine status and expectation of having
sex in the next year; however cervical screening intentions were
associated with vaccine status. Those with low intentions to attend
cervical screening in the future were signiﬁcantly less likely to be
fully vaccinated compared with those who  had high intentions (70%
vs. 81%). This association remained signiﬁcant after adjusting for
ethnicity and religion.
4. DiscussionThis study showed that compared with fully vaccinated girls,
those who  had not received all three doses were more likely to be
from non-white ethnic backgrounds and to have lower intentions
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Table  1
Descriptive characteristics of the total sample (N = 1912).
Total (N = 1912a) Column% (n)
2008/9 cohort (n = 918a) 2009/10 cohort (n = 994a) X2 (p-value)
Vaccine status .070
Fully  vaccinated 78.4 (1499) 80.2 (736) 76.8 (763)
Un/under-vaccinated 21.6 (413) 19.8 (182) 23.2 (231)
Ethnicity .327
White 44.2 (845) 44.9 (412) 43.6 (433)
Asian 19.2 (367) 19.1 (175) 19.3 (192)
Black 22.0 (421) 23.0 (211) 21.1 (210)
Other 13.7 (262) 12.3 (113) 15.0 (149)
Religion .035
Christian 42.6 (814) 45.4 (417) 39.9 (397)
None 30.0 (573) 27.0 (248) 32.7 (325)
Muslim 18.7 (357) 18.7 (172) 18.6 (185)
Other 8.2 (157) 8.4 (77) 8.0 (80)
Religiosity .980
Practising 40.1 (767) 41.6 (382) 38.7 (385)
Not practising 29.4 (563) 30.5 (280) 28.5 (283)
Family Afﬂuence Scale .156
Low  afﬂuence (0–4) 29.1 (556) 28.4 (257) 30.5 (299)
Medium afﬂuence (5–6) 37.2 (711) 40.0 (362) 35.6 (349)
High afﬂuence (7–10) 32.3 (618) 31.7 (287) 33.8 (331)
Smoking status .159
No  85.4 (1632) 84.3 (774) 86.3 (858)
Yes  12.8 (245) 13.9 (128) 11.8 (117)
Sexual experience (vaginal sex) .031
No  78.5 (1500) 80.4 (716) 84.2 (784)
Yes  16.8 (322) 19.6 (175) 15.8 (147)
Cervical screening intention .002
Low  (2–6) 22.9 (437) 23.7 (189) 29.8 (248)
Medium (7–8) 36.0 (688) 41.7 (333) 42.6 (355)
High (9–10) 26.5 (506) 34.6 (276) 27.6 (230)
Expectation of having sex in the next year .226
No expectation (2) 36.2 (692) 37.9 (329) 39.6 (363)
Low expectation (3–5) 19.5 (373) 19.8 (172) 21.9 (201)
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a n varies because of missing data.
o attend for cervical screening in the future. These results sup-
ort previous studies that suggest non-white ethnicity is associated
ith being un/under-vaccinated [19–21] and that unvaccinated
irls may  be less likely to attend cervical screening [28,29].
ncouragingly, we found no evidence of an association between
accination status and socioeconomic status, sexual behaviour or
igarette smoking; again, supporting previous ﬁndings that vacci-
ation status does not inﬂuence sexual behaviour [38,39] and that
overage is not associated with area-level deprivation [25]. It is
ikely that the association between vaccination uptake and partic-
pation in screening is explained by a general interest in health
mong those who engage in health protective behaviours. Alter-
atively, some studies suggest that women who attend cervical
creening are more likely to vaccinate their daughters against HPV
40–43], so it is possible that the screening intentions expressed
y the vaccinated girls in our sample were reﬂective of their moth-
rs’ behaviour. We  did not measure parental screening behaviour,
ut future studies should consider this possibility. Exposure to
nformation about cervical screening during the HPV vaccina-
ion campaign (through leaﬂets, providers or discussions with
heir parents) could also explain increased intention to attend for
creening in vaccinated girls, although all girls offered the vac-
ine are exposed to written information on screening, regardless of
ptake. In additional analyses (not reported here) the association
etween vaccination status and intention to be screened remained
igniﬁcant after adjusting for previous awareness of cervical cancer
creening, suggesting that attitudes rather than knowledge under-
in this association.
The association between vaccination status and screening inten-
ion is concerning because it suggests there will be a distinct group2.3 (368) 38.5 (353)
of women  who  remain unvaccinated and unscreened, and will
therefore be at increased risk of cervical cancer. If this is the case, the
expected impact of the vaccination programme on cervical cancer
mortality, as estimated in modelling studies [4], may  be reduced.
It will therefore be critically important to highlight the need for
screening, particularly for unvaccinated women, in materials sent
with future screening invitations to these cohorts. Of course, this
study measured screening intention almost 10 years before girls
were due to be invited, and it is unclear to what extent this will
reﬂect their future behaviour.
The ﬁndings relating to ethnicity are also concerning, particu-
larly as fewer women from non-white ethnic backgrounds tend to
be screened for cervical cancer in the UK and elsewhere [6,44]. Rates
of cervical cancer in women  from black and Asian backgrounds have
been found to be higher than for white women  in the 65+ age-group
[45]. Incidence in women under 65 is currently lower among Asian
women but is similar among black and white women, so lower vac-
cine uptake in black girls is of particular concern. Uptake may  be low
in non-white ethnic groups due to cultural barriers and parental
concerns that vaccination may  encourage sexual activity [46]. Stud-
ies have suggested the role of social sources of information and
discussion (e.g. hearing about the HPV vaccine and discussing it
with family or friends) are important for increasing perceived vac-
cine effectiveness [47] and increasing requests for the vaccine [48].
This supports previous research showing cues to action (e.g. a rec-
ommendation from friends, family or a doctor) are the strongest
predictors of vaccine uptake [49]. These factors should be taken into
consideration when developing health promotion campaigns (e.g.
narrative leaﬂets) aimed at reducing ethnic inequalities in vaccine
uptake.
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Table 2
Demographic and lifestyle predictors of being fully vaccinated against HPV, clustering by school and cohort (n = 1912a).
Row% Fully
vaccinated
(n = 1499a)
Row%
Un/under-
vaccinated
(n = 413a)
Unadjusted analyses Adjusted analyses (n = 1608)
OR (95% CI) p-Value OR (95% CI) p-Value
Demographic risk factors
Ethnicity
White 85.4 (722) 14.6 (123) 1.00 1.00
Asian  77.7 (285) 22.3 (82) 0.59 (0.38–0.93) .023 0.67 (0.38–1.19) .162
Black  68.6 (289) 31.4 (132) 0.37 (0.24–0.59) <.0001 0.41 (0.27–0.60) <.0001
Other  74.0 (194) 26.0 (68) 0.49 (0.34–0.69) <.0001 0.56 (0.38–0.82) .005
Religion
Christian 76.7 (624) 23.3 (190) 1.00 1.00
None  85.3 (489) 14.7 (84) 1.77 (1.16–2.70) .010 1.28 (0.88–1.86) .453
Muslim 70.3 (251) 29.7 (106) 0.72 (0.51–1.02) .065 0.77 (0.52–1.15) .186
Other  80.9 (127) 19.1 (30) 1.29 (0.69–2.41) .410 1.28 (0.66–2.51) .194
Religiosity
Practising 73.0 (560) 27.0 (207) 1.00
Not practising 79.0 (445) 21.0 (118) 1.39 (0.99–1.96) .054
Family Afﬂuence Scale
High afﬂuence (7–10) 81.9 (506) 18.1 (112) 1.00
Medium afﬂuence (5–6) 77.9 (544) 22.1 (157) 0.78 (0.61–1.01) .056
Low  afﬂuence (0–4) 76.1 (423) 23.9 (133) 0.70 (0.47–1.06) .091
Behavioural risk factors
Smoking status
No 78.4 (1280) 21.6 (352) 1.00
Yes 78.8 (193) 21.2 (52) 0.98 (0.65–1.47) .918
Sexual experience (vaginal sex)
No 78.9 (1184) 21.1 (316) 1.00
Yes 78.0 (251) 22.0 (71) 0.94 (0.68–1.31) .717
Cervical screening intention
High intention (9–10) 81.4 (412) 18.6 (94) 1.00 1.00
Medium intention (7–8) 77.9 (536) 22.1 (152) 0.81 (0.55–1.18) .248 0.87 (0.60–1.27) .467
Low  intention (2–6) 70.3 (307) 29.7 (130) 0.54 (0.39–0.75) .001 0.63 (0.45–0.89) .010
Expectation of having sex in the next year
High expectation (6–10) 81.7 (589) 18.3 (132) 1.00
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No  expectation (2) 76.2 (527) 23.8 (165) 
a n may  vary because of missing data, bold text indicates signiﬁcance at p < .05.
As increasing numbers of countries, including the UK, move to
 two-dose HPV vaccine schedule [50], ethnic inequalities might
e reduced. Research in the US has shown that ethnic disparities
ccur mainly between initiators and completers, with those from
on-white ethnic backgrounds being equally likely to initiate but
ess likely to complete the three dose course [51]. As we had a
ingle response category for ‘1–2’ doses, we were unfortunately
nable to explore predictors of receipt of two or more doses in our
ample.
This study beneﬁted from a large sample size, including girls
rom a variety of ethnic and socioeconomic backgrounds. Response
ates in both waves of data collection were very high at over 98%
ut we acknowledge that there could be systematic differences
etween the schools that readily agreed to take part in the study
nd those that refused or failed to respond to our initial contact.
n addition, a signiﬁcant number of girls were absent at the point
f data collection or did not know their vaccine status, which may
educe the generalisability of the ﬁndings. Because recruitment was
imited to London, and to schools with levels of vaccine coverage
ithin 10% of the national average, the results may  not be general-
sable to England more widely or to schools where uptake is much
igher or lower.
Self-reported uptake of the three-dose vaccine among girls in
ur sample (80% and 77% in the ﬁrst and second cohorts respec-
ively) was similar to ﬁgures for national uptake (84% in 2008/9;
1% in 2009/10) [1]. Our ﬁndings are likely to be more generalisable
han those of previous studies in cohorts offered the HPV vac-
ine opportunistically [26,27]. Vaccination status was self-reported
hich may  have limited reliability 3 years post-vaccination. Around1.07 (0.74–1.55) .721
1.40 (0.90–2.16) .127
10% of respondents did not know their vaccine status, and there
was some variation between reported levels of vaccination in our
sample and levels recorded by the Primary Care Trusts in which
the schools were located (data not reported). We  were unable to
validate individual-level vaccine status due to the need to assure
anonymity. As estimates of the accuracy of self-reported HPV vac-
cine status vary, more research in this context is warranted [52,53].
The 10% of girls who  responded ‘don’t know’ to the vaccine sta-
tus question were similar in terms of demographic and behavioural
risk factors to girls who  were un/under-vaccinated (analyses not
reported). We  repeated our regression analyses including these
girls in the un/under-vaccinated group, and found very similar
results to those reported here, suggesting that these girls were
unlikely to be fully vaccinated.
5. Conclusion
Our results suggest that un/under-vaccinated girls in England
may  be at disproportionately greater risk of cervical cancer due not
only to their vaccine status, but also their low screening intentions.
Efforts will be needed to ensure that un/under-vaccinated women
understand the importance of cervical screening when they reach
the age that screening invitations begin. There is also an urgent
need to understand ethnic inequalities in vaccination uptake.Conﬂict of interests
All authors declare no conﬂict of interest that may  have inﬂu-
enced this work.
ccine 3
C
a
t
t
F
C
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[H.L. Bowyer et al. / Va
ontributions
JW conceptualised and designed the study. HB and JW collected
nd analysed the data for the study and all authors contributed to
he interpretation and the writing of this paper and have approved
he ﬁnal draft.
unding
This study was funded as part of a larger project grant from
ancer Research UK (Grant reference A13254).
eferences
[1] Department of Health. Annual HPV vaccine uptake in England, 2010/2011.
http://media.dh.gov.uk/network/211/ﬁles/2012/03/120319 HPV Uptake
Report2010-11-revised acc.pdf [accessed 8.01.12].
[2] Health and Social Care Information Centre Website. Cervical Screening
Programme – England, 2012–2013. https://catalogue.ic.nhs.uk/publications/
screening/cervical/cerv-scre-prog-eng-2012-13/cerv-scre-prog-eng-2012-13-
rep.pdf [accessed 7.11.13].
[3] Cancer Research UK Website. Cervical cancer statistics. http://www.
cancerresearchuk.org/cancer-info/cancerstats/types/cervix/ [accessed
28.08.13].
[4] Cuzick J, Castanon A, Sasieni P. Predicted impact of vaccination against
human papillomavirus 16/18 on cancer incidence and cervical abnormalities
in women aged 20–29 in the UK. Br J Cancer 2010;102(March (5)):933–9,
http://dx.doi.org/10.1038/sj.bjc.6605528.
[5] Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age:
population based case-control study of prospectively recorded data. BMJ
2009;339:b2968, http://dx.doi.org/10.1136/bmj.b2968.
[6] Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cer-
vical screening in Great Britain: analysis of cross sectional survey data. BMJ
2009;338:b2025, http://dx.doi.org/10.1136/bmj.b2025.
[7] Baker D, Middleton E. Cervical screening and health inequality in England in
the  1990. J Epidemiol Commun Health 2003;57:417–23.
[8] Webb R, Richardson J, Pickles A. A population-based study
of  primary care predictors of non-attendance for cervi-
cal screening. J Med  Screen 2004;11(September (3)):135–40,
http://dx.doi.org/10.1258/0969141041732166.
[9]  Sutton S, Rutherford C. Sociodemographic and attitudinal correlates of cervi-
cal screening uptake in a national sample of women in Britain. Soc Sci Med
2005;61(11):2460–5, http://dx.doi.org/10.1016/j.socscimed.2005.07.017.
10] Kjaer S, Chackerian B, van den Brule AJC, Svare EI, Paull G, Walbomers JMM,
et  al. High-risk human papillomavirus is sexually transmitted: evidence from
a  follow-up study of virgins starting sexual activity (intercourse). Cancer Epi-
demiol Biomarkers Prev 2001;10:101–6.
11] Fonseca-Moutinho JA. Smoking and cervical cancer. ISRN Obstet Gynecol
2011;2011:847684, http://dx.doi.org/10.5402/2011/847684.
12] Deacon J, Evans CD, Yule R, Desai M,  Binns W,  Taylor C, et al. Sexual behaviour
and smoking as determinants of cervical HPV infection and of CIN3 among
those infected: a case–control study nested within the Manchester cohort. Br J
Cancer 2000;88(11):1565–72, http://dx.doi.org/10.1054/bjoc.2000.1523.
13] Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Cross-
ley B, et al. Risk factors for adenocarcinoma and squamous cell carcinoma
of  the cervix in women aged 20–44 years: the UK National Case-Control
Study of Cervical Cancer. Br J Cancer 2003;89(December (11)):2078–86,
http://dx.doi.org/10.1038/sj.bjc.6601296.
14] Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M.  Socioeconomic sta-
tus and smoking: a review. Ann N Y Acad Sci 2012;1248(1):107–23,
http://dx.doi.org/10.1111/j. 1749-6632.2011.06202.x.
15]  Tyas SL, Pederson LL. Psychosocial factors related to adolescent smoking: a
critical review of the literature. Tob Control 1998;7(4 (December 1)):409–20,
http://dx.doi.org/10.1136/tc.7.4.409.
16] Fenton KA, Mercer CH, McManus S, Erens B, Wellings K, Macdowall W,  et al.
Ethnic variations in sexual behaviour in Great Britain and risk of sexually
transmitted infections: a probability survey. Lancet 2005;365(9466):1246–55,
http://dx.doi.org/10.1016/S0140-6736(05)74813-3.
17] Wellings K, Nanchahal K, Macdowall W,  McManus S, Erens
B,  Mercer CH, et al. Sexual behaviour in Britain: early
heterosexual experience. Lancet 2001;358(9296):1843–50,
http://dx.doi.org/10.1016/s0140-6736(01)06885-4.
18] Mercer CH, Tanton C, Prah P, Erens B, Sonnenberg P, Clifton S, et al.
Changes in sexual attitudes and lifestyles in Britain through the life
course and over time: ﬁndings from the National Surveys of Sex-
ual  Attitudes and Lifestyles (Natsal). Lancet 2013;382(9907):1781–94,
http://dx.doi.org/10.1016/S0140-6736(13)62035-8.
19] Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, et al. Uptake
of  ﬁrst two doses of human papillomavirus vaccine by adolescent schoolgirls
[2 (2014) 4310–4316 4315
in Manchester: prospective cohort study. BMJ  2008;336(May (7652)):1056–8,
http://dx.doi.org/10.1136/bmj.39541.534109.BE.
20] Perkins RB, Pierre-Joseph N, Marquez C, Iloka S, Clark JA. Parents’ opin-
ions of mandatory human papillomavirus vaccination: does ethnicity
matter? Womens Health Issues 2010;20(November–December (6)):420–6,
http://dx.doi.org/10.1016/j.whi.2010.07.001.
21] Fisher H, Trotter CL, Audrey S, Macdonald-Wallis K, Hickman M.
Inequalities in the uptake of human papillomavirus vaccination: a
systematic review and meta-analysis. Int J Epidemiol 2013;(April),
http://dx.doi.org/10.1093/ije/dyt049.
22] Desai S, Soldan K, White J, Sheridan A, Gill ON. Human papillomavirus vaccine
coverage. Lancet 2010;376:328–9.
23] Roberts SA, Brabin L, Stretch R, Baxter D, Elton P, Kitchener H, et al.
Human papillomavirus vaccination and social inequality: results from a
prospective cohort study. Epidemiol Infect 2011;139(March (3)):400–5,
http://dx.doi.org/10.1017/S095026881000066X.
24] Fisher H, Audrey S, Mytton JA, Hickman M,  Trotter C. Examining
inequalities in the uptake of the school-based HPV vaccination pro-
gramme  in England: a retrospective cohort study. J Public Health 2013
Apr 25, http://dx.doi.org/10.1093/pubmed/fdt042. http://dx.doi.org/10.1093/
pubmed/fdt042
25] Hughes A, Mesher D, White J, Soldan K. Coverage of the English National human
papillomavirus (HPV) Immunisation Programme among 12 to 17 year old
females by area-level deprivation score, England, 2008 to 2011. Euro Surveill
2014;19(2):1–6.
26] Mather T, McCaffery K, Juraskova I. Does HPV vaccination
affect women’s attitudes to cervical cancer screening and
safe sexual behaviour? Vaccine 2012;30(May (21)):3196–201,
http://dx.doi.org/10.1016/j.vaccine.2012.02.081.
27] Kuitto K, Pickel S, Neumann H, Jahn D, Metelmann H-R. Attitudinal
and  socio-structural determinants of cervical cancer screening and HPV
vaccination uptake: a quantitative multivariate analysis. J Public Health
2010;18(2):179–88, http://dx.doi.org/10.1007/s10389-009-0308-z.
28] Paul-Ebhohimhen V, Huc S, Tissington H, Oates K, Start C. HPV vaccination:
vaccine acceptance, side effects and screening intentions. Community Pract
2010;83(6):30–3.
29] Beer H, Hibbitts S, Brophy S, Rahman MA,  Waller J, Paranjothy S.
Does the HPV vaccination programme have implications for cervical
screening programmes in the UK? Vaccine 2014;32(April (16)):1828–33,
http://dx.doi.org/10.1016/j.vaccine.2014.01.087.
30] Department of Health. Annual HPV vaccine uptake in England: 2008/2009;
2010 http://webarchive.nationalarchives.gov.uk/20100305101945/http:/
www.dh.gov.uk/dr consum dh/groups/dh digitalassets/@dh/@en/@ps/
documents/digitalasset/dh 111676.pdf [accessed 8.11.13].
31] Gov.UK Website (2013). Apply for free school meals. https://www.gov.uk/
apply-free-school-meals [accessed 8.11.13].
32] The Poverty Site. UK: concentrations of poor children. http://www.poverty.
org.uk/19/index.shtml [accessed 24.06.13].
33] The Telegraph. 2010 KS4 school league tables. http://schools.tmg.
daltonﬁrth.co.uk/results/ks4/2010/by/REGCODE.LEA [accessed 27.07.12].
34] Bowyer HL, Marlow LA, Hibbitts S, Pollock KG,  Waller J. Knowledge and
awareness of HPV and the HPV vaccine among young women in the ﬁrst rou-
tinely vaccinated cohort in England. Vaccine 2013;31(February (7)):1051–6,
http://dx.doi.org/10.1016/j.vaccine.2012.12.038.
35] Boyce W,  Torsheim T, Currie C, Zambon A. The family afﬂuence scale as a mea-
sure of national wealth: validation of an adolescent self-report measure. Soc
Indic Res 2006;78(3):473–87, http://dx.doi.org/10.1007/s11205-005-1607-6.
36] Sheeran P, Orbell S. Using implementation intentions to increase atten-
dance for cervical cancer screening. Health Psychol 2000;19(May (3)):283–9,
http://dx.doi.org/10.1037/0278-6133.19.3.283.
37] IBM. SPSS Statistics for Windows (version 20.0) [Computer Program] IBM Corp.
Armonk, NY.
38] Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J. Human papil-
lomavirus vaccination and sexual behaviour: cross-sectional and longitu-
dinal surveys conducted in England. Vaccine 2012;30(July (33)):4939–44,
http://dx.doi.org/10.1016/j.vaccine.2012.05.053.
39] Bednarczyk RA, Davis R, Ault K, Orenstein W,  Omer SB. Sexual
activity-related outcomes after human papillomavirus vaccination
of  11- to 12-year-olds. Pediatrics 2012;130(November (5)):798–805,
http://dx.doi.org/10.1542/peds. 2012-1516.
40] Chao C, Slezak JM,  Coleman KJ, Jacobsen SJ. Papanicolaou screening
behavior in mothers and human papillomavirus vaccine uptake in
adolescent girls. Am J Public Health 2009;99(June (6)):1137–42,
http://dx.doi.org/10.2105/AJPH.2008.147876.
41] Lefevere E, Hens N, Theeten H, Van den Bosch K, Beutels P, De
Smet F, et al. Like mother, like daughter? Mother’s history of cer-
vical cancer screening and daughter’s Human Papillomavirus vaccine
uptake in Flanders (Belgium). Vaccine 2011;29(October (46)):8390–6,
http://dx.doi.org/10.1016/j.vaccine.2011.08.039.
42] Spencer Nee Pilkington AM,  Brabin L, Verma A, Roberts SA. Mothers’
screening histories inﬂuence daughters’ vaccination uptake: an analysis of
linked cervical screening and human papillomavirus vaccination records
in the North West of England. Eur J Cancer 2013;49(April (6)):1264–72,
http://dx.doi.org/10.1016/j.ejca.2012.12.001.
4 ccine 3
[
[
[
[
[
[
[
[
[
[316 H.L. Bowyer et al. / Va
43] Steens A, Wielders CC, Bogaards JA, Boshuizen HC, de Greeff SC, de Melker
HE.  Association between human papillomavirus vaccine uptake and
cervical cancer screening in the Netherlands: implications for future
impact on prevention. Int J Cancer 2013;132(February (4)):932–43,
http://dx.doi.org/10.1002/ijc.27671.
44] Chen HY, Kessler CL, Mori N, Chauhan SP. Cervical cancer screening
in  the United States, 1993–2010: characteristics of women  who are
never screened. J Womens Health 2012;21(November (11)):1132–8,
http://dx.doi.org/10.1089/jwh.2011.3418.
45] National Cancer Intelligence Network. Cancer incidence and sur-
vival by major ethnic group, England, 2002–2006. http://publications.
cancerresearchuk.org/downloads/product/CS REPORT INCSURV ETHNIC.pdf
[accessed 8.11.13].
46] Marlow LA, Wardle J, Forster AS, Waller J. Ethnic differences
in  human papillomavirus awareness and vaccine acceptability. J
Epidemiol Community Health 2009;63(December (12)):1010–5,
http://dx.doi.org/10.1136/jech.2008.085886.47] Casillas A, Singhal R, Tsui J, Glenn BA, Bastani R, Mangione CM.  The impact of
social communication on perceived HPV vaccine effectiveness in a low-income,
minority population. Ethn Dis 2011;21:495–501.
48] Javanbakht M,  Stahlman S, Walker S, Gottlieb S, Markowitz L, Lid-
don N, et al. Provider perceptions of barriers and facilitators of HPV
[2 (2014) 4310–4316
vaccination in a high-risk community. Vaccine 2012;30(June (30)):4511–6,
http://dx.doi.org/10.1016/j.vaccine.2012.04.062.
49] Bynum SA, Brandt HM,  Sharpe PA, Williams MS, Kerr JC. Working to close
the gap: identifying predictors of HPV vaccine uptake among young African
American women. J Health Care Poor Underserved 2011;22(May (2)):549–61,
http://dx.doi.org/10.1353/hpu.2011.0060.
50] Department of Health. Change in schedule from three to two  doses in
the HPV vaccination programme; 2014 https://www.gov.uk/government/
uploads/system/uploads/attachment data/ﬁle/310958/HPV Joint Letter 14
May.pdf [accessed 16.05.14].
51] Chao C, Velicer C, Slezak JM,  Jacobsen SJ. Correlates for comple-
tion of a 3-dose regimen of HPV vaccine in female members of a
managed care organization. Mayo Clin Proc 2009;84(10):864–70,
http://dx.doi.org/10.1016/S0025-6196(11)60503-X.
52] Rolnick SJ, Parker ED, Nordin JD, Hedblom BD, Wei  F, Kerby T, et al.
Self-report compared to electronic medical record across eight adult vac-
cines: do results vary by demographic factors? Vaccine 2013;31(37):3928–35,
http://dx.doi.org/10.1016/j.vaccine.2013.06.041.
53] Stupiansky NW,  Zimet GD, Cummings T, Fortenberry JD, Shew M. Accuracy
of  self-reported human papillomavirus vaccine receipt among adolescent
girls and their mothers. J Adolesc Health 2012;50(January (1)):103–5,
http://dx.doi.org/10.1016/j.jadohealth.2011.04.010.
